Advanced Heart Failure — Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure
Citation(s)
Double-blind Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of Intermittent, Long-term Administration of Levosimendan in Patients With Advanced Heart Failure